Knut Lote

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Einar Osland Vik-Mo, Marta Nyakas, Birthe Mikkelsen et al. · Cancer Immunology Immunotherapy · 2013 · 302 citations · Full text

Central nervous system involvement following diagnosis ofnon-Hodgkin’s lymphoma: a risk model

Åse Hollender, Ole Nome, Eva Skovlund et al. · Annals of Oncology · 2002 · 260 citations

Neuro-oncology, Lymphoid Neoplasia, Risk Model +5

Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.

Knut Lote, Thore Egeland, Bjarne Hager et al. · Journal of Clinical Oncology · 1997 · 236 citations

Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme

Ragnhild Helseth, Eirik Helseth, Tom Børge Johannesen et al. · Acta Neurologica Scandinavica · 2010 · 213 citations

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis

Glenn Bauman, Knut Lote, David A. Larson et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 193 citations